Additional file 5: Figure S3. of Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease

Therapeutic treatment of miR-223 antagomir in mice with TNBS-induced colitis. A Dose-dependent study of miR-223 antagomir. B Representative images of the colon in treated mice with colitis. C Antagomir223 therapy reduces the histological score. D Effects on MPO activity measurement by antagomir223. E MiR-223 antagomirs downregulate miR-223. *P <0.05, **P <0.01, ***P <0.001. (EPS 4652 kb)